A detailed history of Gamma Investing LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 1,288 shares of EWTX stock, worth $40,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,288
Previous 1,187 8.51%
Holding current value
$40,494
Previous $21.4 Million 60.81%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$15.88 - $29.5 $1,603 - $2,979
101 Added 8.51%
1,288 $34.4 Million
Q2 2024

Jul 02, 2024

SELL
$15.08 - $21.23 $286 - $403
-19 Reduced 1.58%
1,187 $21.4 Million
Q1 2024

Apr 05, 2024

BUY
$9.25 - $19.97 $925 - $1,997
100 Added 9.04%
1,206 $22 Million
Q4 2023

Feb 01, 2024

BUY
$5.51 - $12.1 $6,094 - $13,382
1,106 New
1,106 $19.7 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.99B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.